|
1
|
Lee HJ, Seo M and Lee EJ: Salvianolic acid
B inhibits atherogenesis of vascular cells through induction of
Nrf2-dependent heme oxygenase-1. Curr Med Chem. 21:3095–3106. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guan Y, Zhu JP, Shen J, Jia YL, Jin YC,
Dong XW and Xie QM: Salvianolic acid B improves airway
hyperresponsiveness by inhibiting MUC5AC overproduction associated
with Erk1/2/P38 signaling. Eur J Pharmacol. 824:30–39. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan ZK, Lv G, Wang YF, Li G, Yu DS, Wang
YS, Zhang YQ, Mei XF and Cao Y: The protective effect of
salvianolic acid B on blood-spinal cord barrier after compression
spinal cord injury in rats. J Mol Neurosci. 51:986–993. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu Z, Li JN, Bai ZQ and Lin X: Antagonism
by salvianolic acid B of lipopolysaccharide-induced disseminated
intravascular coagulation in rabbits. Clin Exp Pharmacol Physiol.
41:502–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hao Y, Xie T, Korotcov A, Zhou Y, Pang X,
Shan L, Ji H, Sridhar R, Wang P, Califano J and Gu X: Salvianolic
acid B inhibits growth of head and neck squamous cell carcinoma in
vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int
J Cancer. 124:2200–2209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang ZS, Luo P, Dai SH, Liu ZB, Zheng XR
and Chen T: Salvianolic acid B induces apoptosis in human glioma
U87 cells through p38-mediated ROS generation. Cell Mol Neurobiol.
33:921–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li HB, Lai JP, Jiang Y and Chen F:
Preparative isolation and purification of salvianolic acid B from
the Chinese medicinal plant Salvia miltiorrhiza by
high-speed counter-current chromatography. J Chromatogr A.
943:235–239. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhi W and Deng Q: Purification of
salvianolic acid B from the crude extract of Salvia
miltiorrhiza with hydrophilic organic/salt-containing aqueous
two-phase system by counter-current chromatography. J Chromatogr A.
1116:149–152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Y, Zhu H, Wang J, Liu Z and Bi J:
Isolation and purification of salvianolic acid A and salvianolic
acid B from Salvia miltiorrhiza by high-speed
counter-current chromatography and comparison of their antioxidant
activity. J Chromatogr B Analyt Technol Biomed Life Sci.
877:733–737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuang H, Wang Y, Hu J, Wang C, Lu S and Mo
X: A method for preparation of an internal layer of artificial
vascular graft co-modified with Salvianolic acid B and heparin. Acs
Appl Mater Interfaces. 10:19365–19372. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shang Q, Xu H and Huang L: Tanshinone IIA:
A promising natural cardioprotective agent. Evid Based Complement
Alternat Med. 2012:7164592012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu DM, Wang YJ, Han XR, Wen X, Li L, Xu L,
Lu J and Zheng YL: Tanshinone IIA prevents left ventricular
remodelling via the TLR4/MyD88/NF-κB signalling pathway in rats
with myocardial infarction. J Cell Mol Med. 22:3058–3072. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang XX, Yang JX, Pan YY and Zhang YF:
Protective effects of tanshinone IIA on endothelial progenitor
cells injured by tumor necrosis factor-α. Mol Med Rep.
12:4055–4062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xue Y, Yan J and Feng J: Treatment with
tanshinone IIA suppresses disruption of the blood-brain barrier and
reduces expression of adhesion molecules and chemokines in
experimental autoimmune encephalomyelitis. Eur J Pharmacol.
771:18–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao H, Liu X, Sun W, Kang N, Liu Y, Yang
S, Xu QM, Wang C and Chen X: Total tanshinones exhibits
anti-inflammatory effects through blocking TLR4 dimerization via
the MyD88 pathway. Cell Death Dis. 8:e30042017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao S, Liu Z, Li H, Little PJ, Liu P and
Xu S: Cardiovascular actions and therapeutic potential of
tanshinone IIA. Atherosclerosis. 220:3–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang J, Little PJ and Xu S:
Atheroprotective effects and molecular targets of tanshinones
derived from herbal medicine danshen. Med Res Rev. 38:201–228.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou J, He J, Jin X, Hu T and Zhang Y:
Study on optimisation of extraction process of tanshinone IIA and
its mechanism of induction of gastric cancer SGC7901 cell
apoptosis. Afr J Tradit Complement Altern Med. 10:456–458. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang JB, Wang ZW, Li Y, Huang CQ, Zheng
CH, Li P, Xie JW, Lin JX, Lu J, Chen QY, et al: CDK5RAP3 acts as a
tumor suppressor in gastric cancer through inhibition of β-catenin
signaling. Cancer Lett. 385:188–197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tao L, Wang S, Zhao Y, Sheng X, Wang A,
Zheng S and Lu Y: Phenolcarboxylic acids from medicinal herbs exert
anticancer effects through disruption of COX-2 activity.
Phytomedicine. 21:1473–1482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen GY, Shu YC, Chuang DY and Wang YC:
Inflammatory and apoptotic regulatory activity of tanshinone IIA in
helicobacter pylori-infected cells. Am J Chin Med. 44:1187–1206.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen CY, Li H, Yuan YN, Dai HQ and Yang B:
Antioxidant activity and components of a traditional Chinese
medicine formula consisting of Crataegus pinnatifida and Salvia
miltiorrhiza. BMC Complement Altern Med. 13:992013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang K, Yang Q, Ma Q, Wang B, Wan Z, Chen
M and Wu L: Protective effects of salvianolic acid a against
dextran sodium sulfate-induced acute colitis in rats. Nutrients.
10:E7912018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pasakova I, Klimes J, Sochor J and
Hrabalek A: Optimization of HPLC chromatographic conditions for
determination of Transkarbam 12 and its degradation products. J
Pharm Biomed Anal. 42:136–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo Q, Wang D, Wei Z and Wang Z: Optimized
chromatographic conditions for separation of halogenated acetic
acids by ultra-performance liquid chromatography-electrospray
ionization-mass spectrometry. J Chromatogr A. 1277:26–34. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demiralay EC: An experimental design
approach to optimization of the liquid chromatographic separation
conditions for the determination of metformin and glibenclamide in
pharmaceutical formulation. Acta Chim Slov. 59:307–314.
2012.PubMed/NCBI
|
|
27
|
Jones-Lepp TL and Momplaisir GM: New
applications of LC-MS and LC-MS2 toward understanding
the environmental fate of organometallics. Trac-Trend Anal Chem.
24:590–595. 2005. View Article : Google Scholar
|
|
28
|
Wang Z, Cao B, Yu A, Zhang H and Qiu F:
Ultrasound-assisted ionic liquid-based homogeneous liquid-liquid
microextraction high-performance liquid chromatography for
determination of tanshinones in Salvia miltiorrhiza Bge
root. J Pharm Biomed Anal. 104:97–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Skehan P, Storeng R, Scudiero D, Monks A,
McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR:
New colorimetric cytotoxicity assay for anticancer-drug screening.
J Natl Cancer Inst. 82:1107–1112. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woolston C and Martin S: Analysis of tumor
and endothelial cell viability and survival using sulforhodamine B
and clonogenic assays. Methods Mol Biol. 740:45–56. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fricker SP: The application of
sulforhodamine B as a colorimetric endpoint in a cytotoxicity
assay. Toxicol In Vitro. 8:821–822. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang P and Omaye ST: DNA strand breakage
and oxygen tension: Effects of beta-carotene, alpha-tocopherol and
ascorbic acid. Food Chem Toxicol. 39:239–246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu QP, Cao XM, Hao DL and Zhang LL:
Chemical composition, antioxidant, DNA damage protective, cytotoxic
and antibacterial activities of cyperus rotundus rhizomes essential
oil against foodborne pathogens. Sci Rep. 7:452312017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin Y, Richards FM, Krippendorff BF,
Bramhall JL, Harrington JA, Bapiro TE, Robertson A, Zheleva D and
Jodrell DI: Paclitaxel and CYC3, an aurora kinase A inhibitor,
synergise in pancreatic cancer cells but not bone marrow precursor
cells. Br J Cancer. 107:1692–1701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Di Veroli GY, Fornari C, Goldlust I, Mills
G, Koh SB, Bramhall JL, Richards FM and Jodrell DI: An automated
fitting procedure and software for dose-response curves with
multiphasic features. Sci Rep. 5:147012015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng G, Xiao H, Liu J and Liang X:
Identification of phenolic constituents in Radix Salvia
miltiorrhizae by liquid chromatography/electrospray ionization
mass spectrometry. Rapid Commun Mass Spectrom. 20:499–506. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Xiao S, Sun L, Ge Z, Fang F,
Zhang W, Wang Y and Cheng Y: Rapid screening of bioactive compounds
from natural products by integrating 5-channel parallel
chromatography coupled with on-line mass spectrometry and
microplate based assays. Anal Chim Acta. 777:49–56. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang X, Morris-Natschke SL and Lee KH: New
developments in the chemistry and biology of the bioactive
constituents of Tanshen. Med Res Rev. 27:133–148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong BC, Lam SK, Wong WM, Chen JS, Zheng
TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, et al: Helicobacter
pylori eradication to prevent gastric cancer in a high-risk region
of China: A randomized controlled trial. JAMA. 291:187–194. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zheng X, Chen S, Yang Q, Cai J, Zhang W,
You H, Xing J and Dong Y: Salvianolic acid A reverses the
paclitaxel resistance and inhibits the migration and invasion
abilities of human breast cancer cells by inactivating transgelin
2. Cancer Biol Ther. 16:1407–1414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang QL, Wu Q, Tao YY, Liu CH and
El-Nezami H: Salvianolic acid B modulates the expression of
drug-metabolizing enzymes in HepG2 cells. Hepatobiliary Pancreat
Dis Int. 10:502–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li H, Shi L, Wei J, Zhang C, Zhou Z, Wu L
and Liu W: Cellular uptake and anticancer activity of salvianolic
acid B phospholipid complex loaded nanoparticles in head and neck
cancer and precancer cells. Colloids Surf B Biointerfaces.
147:65–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hao Y, Zhou Y, Ji H, Fang Y, Pang X,
Southerland W, Califano J and Gu X: Salvianolic acid B specifically
inhibits cyclooxygenase-2 in human carcinoma cell lines in vitro
and in vivo. Cancer Res. 68:2008.
|
|
44
|
Yan X, Zhou T, Tao Y, Wang Q, Liu P and
Liu C: Salvianolic acid B attenuates hepatocyte apoptosis by
regulating mediators in death receptor and mitochondrial pathways.
Exp Biol Med (Maywood). 235:623–632. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li H, Wang S, Xie Y, Zhang B, Wang J, Yang
Q and Cao W: Simultaneous determination of danshensu, salvianolic
acid B, and paeonol in ShuangDan oral liquid by HPLC. J AOAC Int.
96:20–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xintian Z and Haibin Q: Characterisation
of the degradation of salvianolic acid B using an on-line
spectroscopic analysis system and multivariate curve resolution.
Phytochem Anal. 23:103–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Luo L, Yang B, Zhang G, Zhu W, Liu Y, Wei
X, Kang X and Qu Z: Degradation kinetics of chlorogenic acid in
honeysuckle during modified atmosphere heat pump drying. Int J
Agric & Biol Eng. 9:159–168. 2016.
|
